期刊文献+

佛波酯磷脂酰-L-丝氨酸(PEPS)中间体的合成工艺改进 被引量:1

Improved synthesis of two intermediates of phorbol ester-phosphatidyl-L-serine
下载PDF
导出
摘要 目的改进佛波酯磷脂酰-L-丝氨酸(PEPS)的中间体3-苄基-2-(8-叔丁基二苯基硅氧辛酰基)-1-三苯甲基-sn-甘油(9)和N-叔丁氧羰基-L-丝氨酸二苯甲酯(11)的合成工艺。方法以D-甘露醇为原料,经丙叉基保护、氧化-还原、苄基保护、脱丙叉保护、选择性保护、酯化、羧基还原、硅烷基保护合成化合物9;以L-丝氨酸为原料,经氨基、羧基保护合成化合物11。结果与结论目标化合物的结构经1H-NMR谱确证,改进后的工艺,缩短了合成路线,简化了柱色谱分离、纯化步骤,具有原料易得,操作简便,成本低廉的优点。 Aim To improve the synthetic procedure of 3- benzyl-2- ( 8- tert-butyldiphenylsilyloxyoctanoyl)- 1- triphenylmethyl-sn-glycerol(9) and N-Boc-L-serine diphenylmethyl ester(11). Methods The compound 9 was synthesized from D-mannitol via eight steps reaction including isopropylidene acetal formation, oxidation-reduction, benzylation, deprotection, selective tritylation of the primary alcohol, esterification, reduction of the carboxylic acid, silylation. The compound 11 was synthesized from L-serine via Boc-protection of amino group and diphenylmethyl ester formation. Results and conclusion The structure of the target compounds were confirmed by ^1H-NMR. A more convenient and efficient procedure was obtained by reducing synthetic steps and using easily available material.
出处 《中国药物化学杂志》 CAS CSCD 2008年第4期268-272,共5页 Chinese Journal of Medicinal Chemistry
基金 国家自然科学基金项目(20172005)
关键词 蛋白激酶C抑制剂 佛波酯磷脂酰-L-丝氨酸 3-苄基-2-(8-叔丁基二苯基硅氧辛酰基)-1-三苯甲基-sn-甘油 N-叔丁氧羰基-L-丝氨酸二苯甲酯 合成 protein kinase C inhibitor phorbol ester-phosphatidyl-L-serine 3-benzyl-2-(8-tert-butyl diphenylsilyloxyoctanoyl)-1-triphenylmethyl-sn-glycerol N-boc-L-serine diphenylmethyl ester synthesis
  • 相关文献

参考文献17

  • 1INOUE M, KISHIMOTO A, TAKAI Y, et al. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. Ⅱ. Proenzyme and its activation by calcium-dependent protease from rat brain[J]. J Biol Chem, 1977, 252(21) : 7610 - 7616.
  • 2BLOBE G C, OBEID L M, HANNUN Y A. Regulation of protein kinase C and role in cancer biology [J]. Cancer Metastasis Rev, 1994, 13(3/4) : 411 - 431.
  • 3HOUSEY G M, JOHNSON M D, HSIAO W L, et al. Overproduction of protein kinase causes disordered growth control in rat fibroblasts[J]. Cell, 1988, 52 (3):343-354.
  • 4FINKENZELLER G, MARME D, HUG H, Inducible overexpression of human protein kinase C in NIH 3T3 fibroblasts results in growth abnormalities [J]. Cell Signal, 1992, 4(2): 163- 177.
  • 5PERSONS D A, WILKINSON W O, BELL R M, et al. Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA[J]. Cell, 1988, 52(3) : 447 - 458.
  • 6GESCHER A. Towards selective pharmacological modulation of protein kinase C-opportunities for the development of novel antineoplastic agents [ J ]. Br J Cancer, 1992, 66( 1 ) :10 - 19.
  • 7BRADSHAW D, HILL C H, WILKINSON S E. Therapeutic potential of protein kinase C inhibitors [J]. Agents Actions, 1993, 38(1/2) : 135 - 147.
  • 8SODEOKA M, MIDORI A A, ADACHI K, et al. Rational design, synthesis and evaluation of a new type of PKC inhibitor[J]. J Am Chem Soc, 1998, 120(2): 457 - 458.
  • 9KO K Y, KIM J Y. Generation of diphenyldiazomethane by oxidation of benzophenone hydrazone with magtrieve[J]. Bull Korean Chem Soc, 1999, 20 (7) :771 - 772.
  • 10LEE R A, DONALD D S. Magtrieve ( tm ) an efficient, magnetically retrievable and recyclable oxidant [ J ]. Tetrahedron Lett, 1997, 38 (22) : 3857 - 3860.

同被引文献44

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部